Many Adults and kids may report shortness of breath after recovery from COVID-19 infection: Study Aditi14 Feb 2024 9:00 AM ISTResearch evidence describes new and persistent symptoms and conditions as potential post-acute sequelae of SARS-CoV-2 infection (PASC).In their recent...
Medical Bulletin 22/August/2023 Isra Zaman22 Aug 2023 3:15 PM ISTHere are the top medical news of the day:Prostate cancer drug potential against COVIDAt the outset of the COVID pandemic, men appeared to suffer...
Prostate cancer drug potential against COVID Isra Zaman22 Aug 2023 9:00 AM ISTAt the outset of the COVID pandemic, men appeared to suffer higher rates of severe illness and death, leading researchers to suspect a link between...
Prolonged damage of nerve cells due to inflammation in nose responsible for sense of smell in COVID19 Dr. Kamal Kant Kohli2 Jan 2023 9:30 AM ISTThe reason some people fail to recover their sense of smell after COVID-19 is linked to an ongoing immune assault on olfactory nerve cells and an...
Cholesterol drug Statins provide protective immune function in females Dr. Kamal Kant Kohli25 Aug 2022 8:00 PM ISTCatherine Andersen, associate professor of nutritional sciences in the College of Agriculture, Health and Natural Resources has found in a new study...
Review: Efficacy of Antiviral Agents Against Omicron Subvariant BA.2 Dr. Kamal Kant Kohli16 May 2022 11:45 AM ISTThe omicron (B.1.1.529) variant of SARS-CoV-2, has spread rapidly around the world and has already become the predominant variant circulating in many...
Fourth dose of Pfizer vaccine may provide additional protection to elderly against severe disease: NEJM Medical Dialogues Editorial Team8 April 2022 10:00 AM ISTIsrael: A new study conducted by Yinon M. Bar-On and the team found that after the fourth dose of BNT162b2 vaccination, rates of confirmed SARS-CoV-2...
Decoding REGEN-COV2 for Mild to Moderate SARS-CoV-2 Infection in Kidney Transplant Recipients Dr. Kamal Kant Kohli17 March 2022 11:45 AM ISTKidney transplant recipients are an immunocompromised population, with comorbid conditions such as obesity, diabetes, and coronary artery disease,...
Casirivimab and imdevimab in patients admitted to hospital with COVID-19: RECOVERY Trial Dr. Kamal Kant Kohli9 March 2022 5:19 PM ISTCasirivimab and imdevimab are non-competing monoclonal antibodies that bind to two different sites on the receptor-binding domain of the SARS-CoV-2...
Decoding safety, tolerability, and pharmacokinetics of Molnupiravir Dr. Kamal Kant Kohli4 Feb 2022 11:56 AM ISTMolnupiravir is a prodrug of active antiviral ribonucleoside analog b-D-N4-hydroxycytidine (NHC; EIDD-1931), with the potential to treat infections...
Quick Review: Effectiveness of REGEN-COV antibody cocktail against B.1.617.2 (delta) variant of SARS-CoV-2 Dr. Kamal Kant Kohli1 Feb 2022 12:34 PM ISTCasirivimab plus imdevimab antibody cocktail (REGEN-COV) has been shown to reduce viral load and prevent symptomatic disease in household contacts of...
Molnupiravir (MK-4482/EIDD-2801) inhibits SARS-CoV-2 replication in Syrian Hamster Model Dr. Kamal Kant Kohli25 Jan 2022 11:04 AM ISTAn effective antiviral against SARS-CoV-2 that could be administered orally for use following high-risk exposure would be of substantial benefit in...
